Age related macular degeneration
Conditions
Interventions
Control group (standard treatment alone):standard treatment
Intervention group (standard treatment + Omega-3 fatty acid supplementation):standard treatment+Omega-3 fatty acid supplements
Sponsors
Shenzhen Eye Hospital
Eligibility
Sex/Gender
All
Age
50 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Diagnosed with AMD;
Exclusion criteria
Exclusion criteria: 1.Uncontrolled glaucoma in the study eye (defined as intraocular pressure >= 30 mmHg despite standard treatment or based on investigator's judgment during screening/baseline). 2.Active intraocular or periocular inflammation/infection (e.g., keratitis). 3.Severe opacity of refractive media in the study eye precluding acquisition of adequate-quality ocular imaging (e.g., SD-OCT, FA, CFP), which may compromise safety/efficacy assessments. 4.Hereditary hemorrhagic tendency or coagulation disorders. 5.Use of Omega-3 dietary supplements within 3 months prior to enrollment. 6.History of vitreous surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| BCVA?OCT?OCTA,Microperimetry,mfERG, Levels of mitophagy-related proteins, Inflammatory markers, Cytokines, Gene expression; | — |
Countries
China
Contacts
Public ContactZhang Shaochong
Shenzhen Eye Hospital
Outcome results
None listed